Study on Severe New Crown Pneumonia Patients with Artificial Liver Treatment
| Title | Study on Severe New Crown Pneumonia Patients with Artificial Liver Treatment |
|---|---|
| Description | Artificial liver system can clear inflammatory mediators to block the cytokine storm, preventing severe cases of COVID-19 from progressing to critically severe type, thus remarkably reducing the fatality rate of severe and critically severe patients. Furthermore, it works more effectively on severe patients in the early stage of cytokine storm and reduces the mortality rate more than 30 % .Early and accurate prediction of which NCP patients will develop into severe and critical conditions, early hierarchical management of these patients, and targeted treatment measures in advance are the keys to reducing mortality, reducing medical burden and maintaining the fight against the epidemic. Screening antiviral drugs with high efficacy is the key to successful treatment. |
| Organism | Homo |
| Data Type | - |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA005133 |
| Release Date | 2021-05-24 |
| Submitter | Mengfei Zhu (13706513269@126.com) |
| Organization | shulang(hangzhou) hospital |
| Submission Date | 2021-05-24 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX325-01-01 | CRF | 1 | Clinical information | 9.6 MB | zip | 0 | Controlled |